Emo, Erlinda D.

HRN: 28-62-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/24/2026
03/03/2026
IVTT
2.25g
Q6H
CAP- High Risk
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: